Global Artificial Tears Market: Large Elderly Population Susceptible to Dry Eyes Syndrome, finds TMR Research

San Francisco, California, Nov 02, 2018: A report by TMR Research, titled, “Artificial Tears Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017–2025,” states that are different factors benefitting the market. Foremost among them is the large pool of elderly population which is growing by the day. This because, owing to weaker eyesight, the aged people are often afflicted with dry eye syndrome. The rising number of eye surgeries warranting management of dry eye condition post surgery also generating considerable demand in global artificial tears market.

Get Sample Copy of this Report @

The different types of artificial tears available in the market can be categorized on the basis of their raw materials into glycerin-based tears, cellulose-derived tears, polyethylene glycol-based tears, propylene glycol-based tears, and oil-based emulsion tears. Among these, the glycerin-based tears are seeing substantial demand in the global artificial tears market because of their easy availability and capacity to keep the eyes moist for a long while. Going forward, however, cellulose-derived tears are expected to see greater uptake owing to the rising preference for natural products over the synthetic ones.

The report predicts that going forward, nimble companies operating in the global artificial tears market will likely tap into the promising and high growth market in emerging nations in Asia Pacific and Latin America. They are seen building products that are more effective and cater to the specific requirements of end users. To that end, they are expending money on research and development of better products.

One factor posing a challenge to the global artificial tears market is the cost conscious consumers in the developing nations who often prefer low cost products. This is dampening revenue growth to an extent. Besides, excess use of artificial tears can also have side effects. Hence, doctors advice limited use.

Read Comprehensive Overview of Report @

Nevertheless, going forward, popularity of preservative-free tears will create new opportunities in the market. Some of the key players in the global artificial tears market are Novartis International AG, AbbottMedical Optics, Santen Pharmaceuticals, Bausch & Lomb, and Allergan Inc.

Dry Eye Syndrome to Drive Adoption of Artificial Tears

San Francisco, California, July 03, 2017: The increasing number of eye problems among the geriatric population is one of the primary causes leading to the high adoption of artificial tears across the globe, states TMR Research in a research report. The report is titled, “Artificial Tears Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025.”

The swiftly rising global geriatric population has a crucial role to play in the progress of the global market for artificial tears. Aging people are more prone to ophthalmic ailments such as dry eye syndrome as aging weakens the eyes, thus causing several eye problems. This is further resulting in an upsurge in the consumption of artificial years. Furthermore, the market is expected to be benefitted with the rising number of people taking up eye surgeries. The treatment of dry eye, which is a usual condition that occurs post to any eye surgery, is especially boosting the demand for artificial tears. Other than this, their generic application also included being applied in the eye of animals a part of the therapy for treating keratoconjuctivitis sicca.

Some of the various forms of artificial tears include based on raw materials include propylene glycol based tears, polyethylene glycol based, oil based emulsion tears, glycerin based tears, and cellulose derived tears. The segment that is expected to exhibit the leading demand is the segment of glycerin based tears owing to their availability in abundance and the capability to maintain the eye moisture for a long time. Nevertheless, a shift of consumers towards cellulose derived tears is anticipated to be witnessed in the years ahead due to the rise in the number of end users preferring natural products for eye treatment. On the basis of delivery, the two conventional dry eye relief procedures are artificial tears and ointments.

The manufactures of artificial tears are expected to capitalize on the opportunities that are likely to be offered in the near future by the developing countries in Latin America and Asia Pacific. The companies that are operating in the market are focusing on the production of high end products and keeping in mind the needs of its consumer base and end users. Thus, to attain this goal, the players are focusing on intense research and development activities for product diversification.

Generally, artificial tears are referred to as eye drops that are employed for lubricating dry eyes and then help to preserve the moisture present on the outer surface of the eye. This has emerged as an effective solution for people suffering from dry eye and other eye ailments. However, prevailing side effects may restrict the market’s growth to some extent. The leading companies operating in the global artificial tears market are Alcon Inc., Bausch & Lomb, McNEIL-PPC, Santen Pharmaceuticals, Novartis International AG, AbbottMedical Optics Inc., Advanced Vision Research Inc., and Allergan Inc.